Cell therapy manufacturing still needs better tech – BioProcess Insider – BioProcess Insider

Cell therapies show real curative potential. However, recently published research suggests the industry still needs faster, more effective production methods to fulfil its potential.
For one thing, turning candidate cell therapies into commercial products will require innovation in manufacturing systems according to a study by researchers at the US National Institutes of Health.
The study – published in International Reviews of Immunology – looked at the use of engineering T cell therapies (including those based on CAR-T cells and TCR-T cells) and found that while production systems have improved there is still more to do.
Image: DepositPhotos/
gwolters
According to the authors “In the past few years there have been a number of technical innovations that enable robust clinical manufacturing in functionally closed and often automated systems.”
However, they go on to say that “Continued improvement in cell manufacturing technology will help enable world-wide implementation of engineered T cell therapies.”
The recommendation is based on the comparative analysis of case studies of engineered T cells manufactured for phase I clinical trials at the NIH Clinical Center in Bethesda, Maryland.
Specifically, the team looked at three different methods used to make CD30 CAR-T cells for the treatment of lymphoma, CD19/CD22 bispecific CAR-T cells as therapies fort a range of B cell malignancies and E7 TCR T cells for human papilloma virus-associated cancers.
The NIH team’s conclusion is in keeping with the findings of researchers at Penn Medicine, who suggested earlier this year that innovation was the key to the growth of the cell therapy sector.
Writing in Nature Biomedical Engineering, the Penn team outlined an accelerated production method that they claim can generate functional CAR-T cells within 24 hours of them being derived from peripheral blood samples.
According to the authors, “The rapid manufacturing of CAR T cells may reduce production costs and broaden their applicability.”
BioProcess Insider, Therapeutic Class



document.getElementById( “ak_js_1” ).setAttribute( “value”, ( new Date() ).getTime() );

source

Share:

More Posts

Market Research

Pulse Surveys

Turn feedback into action

Our survey platform makes it easy to measure and understand feedback so you can drive growth and innovation

Pulse Handshak

Pulse Handshak

Collaborative online survey tool for the market research industry. Remote assisted surveying just like face-to-face interviews. Here interviewers can talk to the respondent over the web-console without the need for any other communication channel and share the same Q're with responses and click actions.

Pulse FE

Pulse FE

Pulse Field Expert or Pulse FE is the main platform for both offline and online survey at softofficepro.com. It is robust and used by hundreds of clients over tens of years with millions of responses. Do it once Q're and deploy on both offline devices (android) and online forms makes it a great cost effective platform for any kind of responses

Pulse Ultimate

Pulse Ultimate

Pulse Ultimate is targeted for tracking studies and retail audits. An offline survey system offering extreme field control including processes like data quality check, back-check, rework, comparison with previous wave data etc. helps to get the best results on a day-to-day basis

Pulse LS

Pulse LS

Use a managed Limesurvey and our expertise for creating complex forms and token based user management. Use optional mailing system to send survey invitation to each participant and track progress of the response status. Industry standard SPSS / R output supported